株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のペプチド医薬品市場 2019年

Global Peptide Therapeutics Sales Market Report 2019

発行 QYResearch 商品コード 387893
出版日 ページ情報 英文 191 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.06円で換算しております。
Back to Top
世界のペプチド医薬品市場 2019年 Global Peptide Therapeutics Sales Market Report 2019
出版日: 2019年05月21日 ページ情報: 英文 191 Pages
概要

世界のペプチド医薬品市場は、過去数年間にわたって平均7.7%のCAGRで急速な成長を遂げ、2017年の収益額は285億米ドル(1億5000万ユニット相当)となりました。

当レポートでは、ペプチド医薬品の世界市場について調査し、市場および製品の概要、売上数・収益額・価格の推移と予測、タイプ・応用領域・地域別の詳細動向、市場成長への影響因子の分析、産業構造、主要企業のプロファイルなどを包括的にまとめています。

第1章 市場概要

  • 製品概要・市場の展望
  • 市場区分:製品タイプ別
    • 注射薬
    • 経口薬
  • 市場区分:応用領域/エンドユーザー別
    • 代謝疾患
    • 中枢神経系
  • 市場区分:地域別
    • 北米
    • 欧州
    • 中国
    • 日本
    • インド
    • 南米
  • ランレオチドの収益額と成長率
  • リラグルチドの収益額と成長率

第2章 競合分析:企業、タイプ、応用領域別

  • 企業の競合情勢
  • タイプ別の売上数・収益額
  • 地域別の売上数・収益額
  • 応用領域別の収益額

第3章 北米のペプチド医薬品市場(売上数・収益額・価格)

  • 売上数と収益額
    • 売上数と成長率
    • 収益額と成長率
    • 販売価格と動向
  • 売上数と市場シェア:企業別
  • 売上数と市場シェア:タイプ別
  • 売上数と市場シェア:応用領域別

第4章 中国のペプチド医薬品市場(売上数・収益額・価格)

  • 売上数と収益額
    • 売上数と成長率
    • 収益額と成長率
    • 販売価格と動向
  • 売上数と市場シェア:企業別
  • 売上数と市場シェア:タイプ別
  • 売上数と市場シェア:応用領域別

第5章 欧州のペプチド医薬品市場(売上数・収益額・価格)

  • 売上数と収益額
    • 売上数と成長率
    • 収益額と成長率
    • 販売価格と動向
  • 売上数と市場シェア:企業別
  • 売上数と市場シェア:タイプ別
  • 売上数と市場シェア:応用領域別

第6章 日本のペプチド医薬品市場(売上数・収益額・価格)

  • 売上数と収益額
    • 売上数と成長率
    • 収益額と成長率
    • 販売価格と動向
  • 売上数と市場シェア:企業別
  • 売上数と市場シェア:タイプ別
  • 売上数と市場シェア:応用領域別

第7章 インドのペプチド医薬品市場(売上数・収益額・価格)

  • 売上数と収益額
    • 売上数と成長率
    • 収益額と成長率
    • 販売価格と動向
  • 売上数と市場シェア:企業別
  • 売上数と市場シェア:タイプ別
  • 売上数と市場シェア:応用領域別

第8章 南米のペプチド医薬品市場(売上数・収益額・価格)

  • 売上数と収益額
    • 売上数と成長率
    • 収益額と成長率
    • 販売価格と動向
  • 売上数と市場シェア:企業別
  • 売上数と市場シェア:タイプ別
  • 売上数と市場シェア:応用領域別

第9章 企業プロファイルと売上データ

  • Sanofi
  • Teva
  • Novo Nordisk
  • Takeda
  • Eli Lilly
  • AstraZeneca
  • Novartis
  • Shire
  • AbbVie
  • Ipsen
  • Allergan
  • Ferring
  • Merck
  • The Medicines
  • Roche
  • J & J

第10章 製造コストの分析

  • 研究開発費の分析
  • 製造コストの内訳
    • 原材料費
    • 人件費
    • その他
  • 製造プロセスの分析

第11章 産業チェーン、調達戦略、下流工程バイヤー

第12章 マーケティング戦略の分析

  • マーケティング経路
  • 市場の位置付け
  • 流通販売業者のリスト

第13章 市場影響因子の分析

  • 技術発展とリスク
  • 消費者ニーズ・消費者選好の変化
  • 経済的・政治的要因

第14章 世界のペプチド医薬品市場の予測

  • 売上数・収益額・価格の予測
  • 売上数・収益額・成長率の予測:地域別
  • 収益額の予測:タイプ別
  • 収益額の予測:応用領域別

第15章 調査結果と総論

第16章 調査手法と参考資料

図表
  • Figure Peptide Therapeutics Product Picture 1
  • Table The Brands of Major Manufacturers 1
  • Table Peptide Drugs in the Global Market 2
  • Table Global Peptide Therapeutics Sales (K Unit) and Revenue (M USD) Growth Rate by Types (2019-2025) 3
  • Figure Global Peptide Therapeutics Revenue Market Share by Types in 2018 3
  • Figure Injection Product Picture 4
  • Figure Oral Product Picture 4
  • Table Global Peptide Therapeutics Revenue (M USD) Comparison by Application (2019-2025) 5
  • Figure Global Sales Market Share of Peptide Therapeutics by Application in 2018 5
  • Figure Cancer Examples 6
  • Figure Metabolic Disorders Examples 6
  • Figure Central Nervous System Examples 7
  • Table Global Market Peptide Therapeutics Revenue (M USD) Comparison by Region 2019-2025 8
  • Figure North America Peptide Therapeutics Revenue (M USD) Growth Rate (2014-2025) 9
  • Figure Europe Peptide Therapeutics Revenue (M USD) Growth Rate (2014-2025) 10
  • Figure China Peptide Therapeutics Revenue (M USD) Growth Rate (2014-2025) 11
  • Figure Japan Peptide Therapeutics Revenue (M USD) Growth Rate (2014-2025) 12
  • Figure South America Peptide Therapeutics Revenue (M USD) Growth Rate (2014-2025) 13
  • Figure India Peptide Therapeutics Revenue (M USD) Growth Rate (2014-2025) 14
  • Figure Global Peptide Therapeutics Sales (K Unit) Growth Rate (2014-2025) 15
  • Figure Global Peptide Therapeutics Revenue (M USD) Growth Rate (2014-2025) 16
  • Table Global Peptide Therapeutics Sales (K Unit) of Key Companies (2018-2019) 17
  • Table Global Peptide Therapeutics Sales Share by Company (2018-2019) 18
  • Figure Global Peptide Therapeutics Sales Share by Company in 2018 19
  • Table Global Peptide Therapeutics Revenue (M USD) by Company (2018-2019) 19
  • Table Global Peptide Therapeutics Revenue Share by Company (2018-2019) 20
  • Figure Global Peptide Therapeutics Revenue Share by Company in 2018 21
  • Table Global Peptide Therapeutics Sales (K Unit) by Region (2014-2019) 21
  • Table Global Peptide Therapeutics Sales Share by Region (2014-2019) 22
  • Figure Global Peptide Therapeutics Sales Share by Region in 2018 22
  • Table Global Peptide Therapeutics Revenue (M USD) by Region (2014-2019) 23
  • Table Global Peptide Therapeutics Revenue Share by Region (2014-2019) 23
  • Figure Global Peptide Therapeutics Revenue Market Share by Region In 2018 24
  • Table Global Peptide Therapeutics Sales (K Unit) by Type (2014-2019) 24
  • Table Global Peptide Therapeutics Sales Share by Type (2014-2019) 24
  • Figure Global Peptide Therapeutics Sales market share by Type in 2018 25
  • Table Global Peptide Therapeutics Revenue (M USD) by Type (2014-2019) 25
  • Figure Global Peptide Therapeutics Revenue Share by Type (2014-2019) 26
  • Figure Global Peptide Therapeutics Revenue Share by Type in 2018 26
  • Table Global Peptide Therapeutics Revenue (M USD) by Application (2014-2019) 27
  • Figure Global Peptide Therapeutics Revenue Share by Application (2014-2019) 27
  • Figure Global Peptide Therapeutics Revenue Market Share by Application in 2018 28
  • Figure North America Peptide Therapeutics Sales (K Unit) Growth Rate (2014-2019) 29
  • Figure North America Peptide Therapeutics Revenue (M USD) Growth Rate (2014-2019) 30
  • Figure North America Peptide Therapeutics Price (USD/Unit) Trend (2014-2019) 31
  • Table North America Peptide Therapeutics Revenue by Company (2018-2019) (M USD) 31
  • Table North America Peptide Therapeutics Sales Market Share by Company (2018-2019) 32
  • Figure North America Peptide Therapeutics Sales Market Share by Company in 2018 33
  • Table North America Peptide Therapeutics Revenue by Type (2014-2019) (M USD) 33
  • Table North America Peptide Therapeutics Revenue Market Share by Type (2014-2019) 34
  • Figure North America Peptide Therapeutics Revenue Market Share by Type in 2018 34
  • Table North America Peptide Therapeutics Revenue by Application (2014-2019) (M USD) 34
  • Table North America Peptide Therapeutics Revenue Market Share by Application (2014-2019) 35
  • Figure North America Peptide Therapeutics Revenue Market Share by Application in 2018 35
  • Figure Europe Peptide Therapeutics Sales (K Unit) Growth Rate (2014-2019) 36
  • Figure Europe Peptide Therapeutics Revenue (M USD) Growth Rate (2014-2019) 37
  • Figure Europe Peptide Therapeutics Price (USD/Unit) Trend (2014-2019) 37
  • Table Europe Peptide Therapeutics Revenue by Company (2018-2019) (M USD) 38
  • Table Europe Peptide Therapeutics Revenue Market Share by Company (2018-2019) 38
  • Figure Europe Peptide Therapeutics Revenue Market Share by Company in 2018 39
  • Table Europe Peptide Therapeutics Revenue by Type (2014-2019) (M USD) 39
  • Table Europe Peptide Therapeutics Revenue Market Share by Type (2014-2019) 40
  • Figure Europe Peptide Therapeutics Revenue Market Share by Type in 2018 40
  • Table Europe Peptide Therapeutics Revenue by Application (2014-2019) (M USD) 40
  • Table Europe Peptide Therapeutics Revenue Market Share by Application (2014-2019) 41
  • Figure Europe Peptide Therapeutics Revenue Market Share by Application in 2018 41
  • Figure China Peptide Therapeutics Sales (K Unit) Growth Rate (2014-2019) 42
  • Figure China Peptide Therapeutics Revenue (M USD) Growth Rate (2014-2019) 43
  • Figure China Peptide Therapeutics Price (USD/Unit) Trend (2014-2019) 44
  • Table China Peptide Therapeutics Revenue (M USD) by Company (2018-2019) 44
  • Table China Peptide Therapeutics Revenue Market Share by Company (2018-2019) 45
  • Figure China Peptide Therapeutics Revenue Market Share by Company in 2018 45
  • Table China Peptide Therapeutics Revenue (M USD) by Type (2014-2019) 46
  • Table China Peptide Therapeutics Revenue Market Share by Type (2014-2019) 46
  • Figure China Peptide Therapeutics Revenue Market Share by Type in 2018 46
  • Table China Peptide Therapeutics Revenue (M USD) by Application (2014-2019) 47
  • Table China Peptide Therapeutics Revenue Market Share by Application (2014-2019) 47
  • Figure China Peptide Therapeutics Revenue Market Share by Application in 2018 47
  • Figure Japan Peptide Therapeutics Sales (K Unit) Growth Rate (2014-2019) 48
  • Figure Japan Peptide Therapeutics Revenue (M USD) Growth Rate (2014-2019) 49
  • Figure Japan Peptide Therapeutics Price (USD/Unit) Trend (2014-2019) 50
  • Table Japan Peptide Therapeutics Revenue (M USD) by Company (2018-2019) 50
  • Table Japan Peptide Therapeutics Revenue Market Share by Company (2018-2019) 51
  • Figure Japan Peptide Therapeutics Revenue Market Share by Company in 2018 51
  • Table Japan Peptide Therapeutics Revenue (M USD) by Type (2014-2019) 52
  • Table Japan Peptide Therapeutics Revenue Market Share by Type (2014-2019) 52
  • Figure Japan Peptide Therapeutics Revenue Market Share by Type in 2018 52
  • Table Japan Peptide Therapeutics Revenue (M USD) by Application (2014-2019) 53
  • Table Japan Peptide Therapeutics Revenue Market Share by Application (2014-2019) 53
  • Figure Japan Peptide Therapeutics Revenue Market Share by Application in 2018 53
  • Figure South America Peptide Therapeutics Sales (K Unit) Growth Rate (2014-2019) 54
  • Figure South America Peptide Therapeutics Revenue (M USD) Growth Rate (2014-2019) 55
  • Figure South America Peptide Therapeutics Price (USD/Unit) Trend (2014-2019) 56
  • Table South America Peptide Therapeutics Revenue (M USD) by Company (2014-2019) 56
  • Table South America Peptide Therapeutics Revenue Market Share by Company (2014-2019) 57
  • Figure South America Peptide Therapeutics Revenue Market Share by Company in 2018 58
  • Table South America Peptide Therapeutics Revenue (M USD) by Type (2014-2019) 58
  • Table South America Peptide Therapeutics Revenue Market Share by Type (2014-2019) 59
  • Figure South America Peptide Therapeutics Revenue Market Share by Type in 2018 59
  • Table South America Peptide Therapeutics Revenue (M USD) by Application (2014-2019) 59
  • Table South America Peptide Therapeutics Revenue Market Share by Application (2014-2019) 60
  • Figure South America Peptide Therapeutics Revenue Market Share by Application in 2018 60
  • Figure India Peptide Therapeutics Sales (K Unit) Growth Rate (2014-2019) 61
  • Figure India Peptide Therapeutics Revenue (M USD) Growth Rate (2014-2019) 62
  • Figure India Peptide Therapeutics Price (USD/Unit) Trend (2014-2019) 63
  • Table India Peptide Therapeutics Revenue (M USD) by Company (2018-2019) 63
  • Table India Peptide Therapeutics Sales Market Share by Company (2018-2019) 64
  • Figure India Peptide Therapeutics Sales Market Share by Company in 2018 64
  • Table India Peptide Therapeutics Revenue (M USD) by Type (2014-2019) 65
  • Table India Peptide Therapeutics Revenue Market Share by Type (2014-2019) 65
  • Figure India Peptide Therapeutics Revenue Market Share by Type in 2018 65
  • Table India Peptide Therapeutics Revenue (M USD) by Application (2014-2019) 66
  • Table India Peptide Therapeutics Revenue Market Share by Application (2014-2019) 66
  • Figure India Peptide Therapeutics Sales Market Share by Application in 2018 66
  • Table Sanofi Company Profile 67
  • Figure Peptide Therapeutics Product Picture of Sanofi 68
  • Table Peptide Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Sanofi 2018-2019 68
  • Table Eli Lilly Company Profile 69
  • Figure Peptide Therapeutics Product Picture of Eli Lilly 70
  • Table Peptide Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Eli Lilly 2018-2019 70
  • Table Novo Nordisk Company Profile 71
  • Figure Peptide Therapeutics Product Picture of Novo Nordisk 72
  • Table Peptide Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Novo Nordisk 2018-2019 72
  • Table Takeda Company Profile 72
  • Figure Peptide Therapeutics Product Picture of Takeda 74
  • Table Peptide Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Takeda 2018-2019 74
  • Table Teva Company Profile 75
  • Figure Peptide Therapeutics Product Picture of Teva 76
  • Table Peptide Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Teva 2018-2019 76
  • Table Novartis Company Profile 77
  • Figure Peptide Therapeutics Product Picture of Novartis 78
  • Table Peptide Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Novartis 2018-2019 78
  • Table AstraZeneca Company Profile 79
  • Figure Peptide Therapeutics Product Picture of AstraZeneca 80
  • Table Peptide Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of AstraZeneca 2018-2019 80
  • Table Ipsen Company Profile 81
  • Figure Peptide Therapeutics Product Picture of Ipsen 82
  • Table Peptide Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Ipsen 2018-2019 82
  • Table AbbVie Company Profile 83
  • Figure Peptide Therapeutics Product Picture of AbbVie 84
  • Table Peptide Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of AbbVie 2018-2019 84
  • Table Allergan Company Profile 85
  • Figure Peptide Therapeutics Product Picture of Allergan 86
  • Table Peptide Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Allergan 2018-2019 86
  • Table Ferring Company Profile 87
  • Figure Peptide Therapeutics Product Picture of Ferring 88
  • Table Peptide Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Ferring 2018-2019 88
  • Table Merck Company Profile 89
  • Figure Peptide Therapeutics Product Picture of Merck 90
  • Table Peptide Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Merck 2018-2019 90
  • Table J & J Company Profile 91
  • Figure Peptide Therapeutics Product Picture of J & J 92
  • Table Peptide Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of J & J 2018-2019 92
  • Table The Medicines Company Profile 93
  • Figure Peptide Therapeutics Product Picture of The Medicines 94
  • Table Peptide Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of The Medicines 2018-2019 94
  • Figure typical phases from research to the market for a drug candidate 96
  • Table Out-of-pocket Preclinical and Clinical Period Cost Per Investigational Biopharmaceutical Compound 97
  • Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound 98
  • Figure Manufacturing Cost Structure of Peptide Therapeutics 98
  • Figure Assessment of API Manufacturing Cost by Region 99
  • Figure USA Labor Cost Analysis 2015-2018 100
  • Figure Cost of Employing a Factory Worker 101
  • Figure Europe Labor Cost Analysis 2015-2018 102
  • Figure Germany Labor Cost Analysis 2015-2018 102
  • Figure UK Labor Cost Analysis 2015-2018 103
  • Figure France Labor Cost Analysis 2015-2018 103
  • Figure Italy Labor Cost Analysis 2015-2018 103
  • Figure Monthly Minimum Wages in Asia 2016 104
  • Figure China Labor Costs 2015-2018 104
  • Figure Japan Average Monthly Wages 2015-2018 105
  • Figure Global Electricity Prices by Select Countries in 2017 (in U.S. Dollars per Kilowatt Hour) 106
  • Table Average Price of Electricity to Ultimate Customers 2007-2018 107
  • Figure Electricity Prices for Household Consumers in 2017 108
  • Table China Cost of Electricity 2017 (PER KWH) 109
  • Figure Manufacturing Process Analysis of Peptide Therapeutics 111
  • Figure Peptide Therapeutics Industrial Chain Analysis 112
  • Table Major Buyers of Peptide Therapeutics 113
  • Figure Market Channel of Peptide Therapeutics 118
  • Figure Setting Pricing Policy 119
  • Table Distributors/Traders List 121
  • Table Market Key Trends 123
  • Table Key Opportunities and Drivers: Impact Analysis (2019-2025) 124
  • Table Key Challenges 124
  • Figure Porter's Five Forces Analysis 125
  • Table GLP-1 Agonists Currently in Clinical or Preclinical Testing 126
  • Table SWOT Analysis of Peptides as Ttherapeutics 127
  • Figure Product Picture of Peptide Cancer Vaccine 128
  • Figure Peptide Cancer Vaccine Product Picture and Specifications of BrightPath Biotherapeutics 129
  • Figure Peptide Cancer Vaccine Product Picture and Specifications of BrightPath Biotherapeutics 129
  • Figure Peptide Cancer Vaccine Product Picture and Specifications of BrightPath Biotherapeutics 130
  • Figure Peptide Cancer Vaccine Product Picture and Specifications of BrightPath Biotherapeutics 130
  • Figure UV1 Technology 132
  • Figure How HER-Vaxx is Tntended to Work 136
  • Figure Molecular Modeling Study-MHC Class II Receptor 139
  • Figure Li Suppression 139
  • Figure Li-KEY Hybrid 140
  • Figure Cancer Incidence by Country in 2016 141
  • Figure Cancer Mortality by Country in 2016 142
  • Figure USA numbers of new cancer cases for 2016 142
  • Figure Global GDP Growth Rate for 2016 143
  • Figure Real GDP Growth 2016-2020 annual Average 144
  • Figure USA GDP 2008-2016 (Billion USD) 145
  • Figure USA GDP Growth Rate Change 2015-2018 146
  • Figure EU GDP 2008-2016 (Billion USD) 146
  • Figure EU GDP Growth Rate Change 2015-2018 147
  • Figure Germany GDP 2008-2016 (Billion USD) 147
  • Figure Germany GDP Growth Rate 2015-2018 147
  • Figure UK GDP 2008-2016 (Billion USD) 148
  • Figure UK GDP Growth Rate 2015-2018 148
  • Figure Italy GDP 2008-2016 (Billion USD) 148
  • Figure Italy GDP Growth Rate 2015-2018 149
  • Figure France GDP 2008-2016 (Billion USD) 149
  • Figure France GDP Growth Rate 2015-2018 149
  • Figure Japan GDP 2008-2016 (Billion USD) 150
  • Figure Japan GDP Growth Rate 2015-2018 150
  • Figure China GDP 2008-2016 (Billion USD) 150
  • Figure China GDP Growth Rate 2015-2018 151
  • Figure Global Peptide Therapeutics Sales (K Unit) Growth Rate Forecast (2019-2025) 152
  • Figure Global Peptide Therapeutics Revenue (M USD) Growth Rate Forecast (2019-2025) 153
  • Figure Global Peptide Therapeutics Price (USD/Unit) Trend Forecast (2019-2025) 154
  • Table Global Peptide Therapeutics Sales (K Unit) Forecast by Region (2019-2025) 154
  • Table Global Peptide Therapeutics Revenue (M USD) Forecast by Region (2019-2025) 155
  • Figure Global Peptide Therapeutics Revenue Market Share Forecast by Region (2019-2025) 155
  • Figure North America Peptide Therapeutics Sales (K Unit) Growth Rate Forecast (2019-2025) 156
  • Figure North America Peptide Therapeutics Revenue (M USD) Growth Rate Forecast (2019-2025) 156
  • Figure Europe Peptide Therapeutics Sales (K Unit) Growth Rate Forecast (2019-2025) 157
  • Figure Europe Peptide Therapeutics Revenue (M USD) Growth Rate Forecast (2019-2025) 157
  • Figure China Peptide Therapeutics Sales (K Unit) Growth Rate Forecast (2019-2025) 158
  • Figure China Peptide Therapeutics Revenue (M USD) Growth Rate Forecast (2019-2025) 158
  • Figure Japan Peptide Therapeutics Sales (K Unit) Growth Rate Forecast (2019-2025) 159
  • Figure Japan Peptide Therapeutics Revenue (M USD) Growth Rate Forecast (2019-2025) 159
  • Figure South America Peptide Therapeutics Sales (K Unit) Growth Rate Forecast (2019-2025) 160
  • Figure South America Peptide Therapeutics Revenue (M USD) Growth Rate Forecast (2019-2025) 160
  • Figure India Peptide Therapeutics Sales (K Unit) Growth Rate Forecast (2019-2025) 161
  • Figure India Peptide Therapeutics Revenue (M USD) Growth Rate Forecast (2019-2025) 161
  • Table Global Peptide Therapeutics Sales (K Unit) Forecast by Type (2019-2025) 162
  • Figure Global Peptide Therapeutics Sales Market Share Forecast by Type (2019-2025) 162
  • Table Global Peptide Therapeutics Revenue (M USD) Forecast by Type (2019-2025) 163
  • Figure Global Peptide Therapeutics Revenue Market Share Forecast by Type (2019-2025) 163
  • Table Global Peptide Therapeutics Price (USD/Unit) Forecast by Type (2019-2025) 163
  • Table Global Peptide Therapeutics Revenue (M USD) Forecast by Application (2019-2025) 164
  • Figure Global Peptide Therapeutics Sales Market Share Forecast by Application (2019-2025) 165
  • Table Research Programs/Design for This Report 168
  • Figure Bottom-up and Top-down Approaches for This Report 170
  • Figure Data Triangulation 171
  • Figure Key Executives Interviewed 172
  • Table Key Data Information from Secondary Sources 173
  • Table Key Data Information from Primary Sources 173
目次

In the last several years, global market of Peptide Therapeutics developed rapidly, with an average growth rate of 4.72%. The major factors that are driving the growth of this market are the rising prevalence of metabolic disorders and the increasing pool of cancer patients. The technological advancements, resulting in a significant reduction in the production cost of peptide drugs, is also boosting this market remarkably. In 2018, global revenue of Peptide Therapeutics is nearly 29.1 billion USD; the actual sales are about 157 million units.

This report studies the global Peptide Therapeutics market status and forecast, categorizes the global Peptide Therapeutics market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, South America, India and Other regions (Middle East & Africa, Central & South America).

Major Peptide Therapeutics manufacturers covered in this report

Sanofi

Eli Lilly

Novo Nordisk

Takeda

Teva

Novartis

AstraZeneca

Ipsen

AbbVie

Allergan

Ferring

Merck

J & J

The Medicines

Segment by Type

Injection

Oral

Other

Segment by Application

Cancer

Metabolic Disorders

Central Nervous System

Other

In view of regional level, this report covers

North America

Europe

China

Japan

India

South America

India

1 Peptide Therapeutics Market Overview 1

  • 1.1 Peptide Therapeutics Product Scope 1
  • 1.2 Peptide Therapeutics Segment by Type 2
    • 1.2.1 Global Peptide Therapeutics Sales Comparison by Types (2019-2025) 3
    • 1.2.2 Injection 4
    • 1.2.3 Oral 4
  • 1.3 Peptide Therapeutics Segment by Application 4
    • 1.3.1 Global Peptide Therapeutics Revenue Comparison by Application (2019-2025) 5
    • 1.3.2 Cancer 6
    • 1.3.3 Metabolic Disorders 6
    • 1.3.4 Central Nervous System 7
  • 1.4 Peptide Therapeutics Segment by Region 7
    • 1.4.1 Global Peptide Therapeutics Revenue Comparison by Region (2019-2025) 8
    • 1.4.2 North America Peptide Therapeutics Status and Prospect (2014-2025) 8
    • 1.4.3 Europe Peptide Therapeutics Status and Prospect (2014-2025) 9
    • 1.4.4 China Peptide Therapeutics Status and Prospect (2014-2025) 10
    • 1.4.5 Japan Peptide Therapeutics Status and Prospect (2014-2025) 11
    • 1.4.6 South America Peptide Therapeutics Status and Prospect (2014-2025) 12
    • 1.4.7 India Peptide Therapeutics Status and Prospect (2014-2025) 13
  • 1.5 Global Peptide Therapeutics Sales and Revenue (2014-2025) 15
    • 1.5.1 Global Peptide Therapeutics Sales Growth Rate (2014-2025) 15
    • 1.5.2 Global Peptide Therapeutics Revenue Growth Rate (2014-2025) 16

2 Peptide Therapeutics by Company, Region, Type and Application 17

  • 2.1 Global Peptide Therapeutics Market Competition by Companies 17
    • 2.1.1 Global Peptide Therapeutics Sales Market Share of Key Companies (2018-2019) 17
    • 2.1.2 Global Peptide Therapeutics Revenue Market Share by Company (2018-2019) 19
  • 2.2 Global Peptide Therapeutics Sales and Revenue by Region 21
    • 2.2.1 Global Peptide Therapeutics Sales Market Share by Region (2014-2019) 21
    • 2.2.2 Global Peptide Therapeutics Revenue by Region (2014-2019) 23
  • 2.3 Global Peptide Therapeutics Sales and Revenue by Type 24
    • 2.3.1 Global Peptide Therapeutics Sales Market Share by Type (2014-2019) 24
    • 2.3.2 Global Peptide Therapeutics Revenue Market Share by Type (2014-2019) 25
  • 2.4 Global Peptide Therapeutics Revenue by Application 27

3 North America Peptide Therapeutics Sales, Revenue and Price 29

  • 3.1 North America Peptide Therapeutics Sales and Revenue (2014-2019) 29
    • 3.1.1 North America Peptide Therapeutics Sales Growth Rate (2014-2019) 29
    • 3.1.2 North America Peptide Therapeutics Revenue Growth Rate (2014-2019) 30
    • 3.1.3 North America Peptide Therapeutics Price Trend (2014-2019) 31
  • 3.2 North America Peptide Therapeutics Revenue Market Share by Company 31
  • 3.3 North America Peptide Therapeutics Revenue Market Share by Type 33
  • 3.4 North America Peptide Therapeutics Revenue Market Share by Application 34

4 Europe Peptide Therapeutics Sales, Revenue and Price 36

  • 4.1 Europe Peptide Therapeutics Sales and Value (2014-2019) 36
    • 4.1.1 Europe Peptide Therapeutics Sales Growth Rate (2014-2019) 36
    • 4.1.2 Europe Peptide Therapeutics Revenue Growth Rate (2014-2019) 37
    • 4.1.3 Europe Peptide Therapeutics Price Trend (2014-2019) 37
  • 4.2 Europe Peptide Therapeutics Revenue by Company 38
  • 4.3 Europe Peptide Therapeutics Revenue by Type 39
  • 4.4 Europe Peptide Therapeutics Revenue by Application 40

5 China Peptide Therapeutics Sales, Revenue and Price 42

  • 5.1 China Peptide Therapeutics Sales and Revenue (2014-2019) 42
    • 5.1.1 China Peptide Therapeutics Sales Growth Rate (2014-2019) 42
    • 5.1.2 China Peptide Therapeutics Revenue Growth Rate (2014-2019) 43
    • 5.1.3 China Peptide Therapeutics Price Trend (2014-2019) 44
  • 5.2 China Peptide Therapeutics Revenue Market Share by Company 44
  • 5.3 China Peptide Therapeutics Revenue by Type 46
  • 5.4 China Peptide Therapeutics Revenue by Application 47

6 Japan Peptide Therapeutics Sales, Revenue and Price 48

  • 6.1 Japan Peptide Therapeutics Sales and Value (2014-2019) 48
    • 6.1.1 Japan Peptide Therapeutics Sales Growth Rate (2014-2019) 48
    • 6.1.2 Japan Peptide Therapeutics Revenue Growth Rate (2014-2019) 49
    • 6.1.3 Japan Peptide Therapeutics Price Trend (2014-2019) 50
  • 6.2 Japan Peptide Therapeutics Revenue Market Share by Company 50
  • 6.3 Japan Peptide Therapeutics Revenue by Type 52
  • 6.4 Japan Peptide Therapeutics Revenue by Application 53

7 South America Peptide Therapeutics Sales, Revenue and Price 54

  • 7.1 South America Peptide Therapeutics Sales and Value (2014-2019) 54
    • 7.1.1 South America Peptide Therapeutics Sales Growth Rate (2014-2019) 54
    • 7.1.2 South America Peptide Therapeutics Revenue Growth Rate (2014-2019) 55
    • 7.1.3 South America Peptide Therapeutics Price Trend (2014-2019) 56
  • 7.2 South America Peptide Therapeutics Revenue by Company 56
  • 7.3 South America Peptide Therapeutics Revenue by Type 58
  • 7.4 South America Peptide Therapeutics Revenue by Application 59

8 India Peptide Therapeutics Sales, Revenue and Price 61

  • 8.1 India Peptide Therapeutics Sales and Value (2014-2019) 61
    • 8.1.1 India Peptide Therapeutics Sales Growth Rate (2014-2019) 61
    • 8.1.2 India Peptide Therapeutics Revenue Growth Rate (2014-2019) 62
    • 8.1.3 India Peptide Therapeutics Price Trend (2014-2019) 63
  • 8.2 India Peptide Therapeutics Revenue by Company 63
  • 8.3 India Peptide Therapeutics Revenue by Type 65
  • 8.4 India Peptide Therapeutics Revenue by Application 66

9 Analysis of Peptide Therapeutics Industry Key Manufacturers 67

  • 9.1 Sanofi 67
    • 9.1.1 Company Profile 67
    • 9.1.2 Product Information 68
    • 9.1.3 Sales, Price, Revenue and Gross Margin 68
  • 9.2 Eli Lilly 69
    • 9.2.1 Company Profile 69
    • 9.2.2 Product Information 70
    • 9.2.3 Sales, Price, Revenue and Gross Margin 70
  • 9.3 Novo Nordisk 71
    • 9.3.1 Company Profile 71
    • 9.3.2 Product Information 72
    • 9.3.3 Sales, Price, Revenue and Gross Margin 72
  • 9.4 Takeda 72
    • 9.4.1 Company Profile 72
    • 9.4.2 Product Information 74
    • 9.4.3 Sales, Price, Revenue and Gross Margin 74
  • 9.5 Teva 75
    • 9.5.1 Company Profile 75
    • 9.5.2 Product Information 76
    • 9.5.3 Sales, Price, Revenue and Gross Margin 76
  • 9.6 Novartis 77
    • 9.6.1 Company Profile 77
    • 9.6.2 Product Information 78
    • 9.6.3 Sales, Price, Revenue and Gross Margin 78
  • 9.7 AstraZeneca 79
    • 9.7.1 Company Profile 79
    • 9.7.2 Product Information 80
    • 9.7.3 Sales, Price, Revenue and Gross Margin 80
  • 9.8 Ipsen 81
    • 9.8.1 Company Profile 81
    • 9.8.2 Product Information 82
    • 9.8.3 Sales, Price, Revenue and Gross Margin 82
  • 9.9 AbbVie 83
    • 9.9.1 Company Profile 83
    • 9.9.2 Product Information 84
    • 9.9.3 Sales, Price, Revenue and Gross Margin 84
  • 9.10 Allergan 85
    • 9.10.1 Company Profile 85
    • 9.10.2 Product Information 86
    • 9.10.3 Sales, Price, Revenue and Gross Margin 86
  • 9.11 Ferring 87
    • 9.11.1 Company Profile 87
    • 9.11.2 Product Information 88
    • 9.11.3 Sales, Price, Revenue and Gross Margin 88
  • 9.12 Merck 89
    • 9.12.1 Company Profile 89
    • 9.12.2 Product Information 90
    • 9.12.3 Sales, Price, Revenue and Gross Margin 90
  • 9.13 J & J 91
    • 9.13.1 Company Profile 91
    • 9.13.2 Product Information 92
    • 9.13.3 Sales, Price, Revenue and Gross Margin 92
  • 9.14 The Medicines 93
    • 9.14.1 Company Profile 93
    • 9.14.2 Product Information 94
    • 9.14.3 Sales, Price, Revenue and Gross Margin 94

10 Peptide Therapeutics Manufacturing Cost Analysis 95

  • 10.1 Peptide Therapeutics R&D Cost Analysis 95
    • 10.1.1 Clinical Phase Costs 96
    • 10.1.2 Capitalized Costs 97
  • 10.2 Proportion of Manufacturing Cost Structure 98
    • 10.2.1 Raw Materials 98
    • 10.2.2 Labor Cost 99
    • 10.2.3 Other Costs Analysis 106
  • 10.3 Manufacturing Process Analysis of Peptide Therapeutics 111

11 Industrial Chain, Sourcing Strategy and Downstream Buyers 112

  • 11.1 Peptide Therapeutics Industrial Chain Analysis 112
  • 11.2 Upstream Raw Materials Sourcing 112
  • 11.3 Downstream Buyers 113

12 Marketing Strategy Analysis, Distributors/Traders 116

  • 12.1 Marketing Channel 116
    • 12.1.1 Direct Marketing 116
    • 12.1.2 Indirect Marketing 117
    • 12.1.3 Marketing Channel Development Trend 118
  • 12.2 Market Positioning 118
    • 12.2.1 Pricing Strategy 118
    • 12.2.2 Brand Strategy 120
  • 12.3 Distributors/Traders List 121

12 Market Dynamics 123

  • 12.1 Market Trends 123
  • 12.2 Opportunities and Drivers 124
  • 12.3 Challenges 124
  • 12.4 Porter's Five Forces Analysis 124

13 Market Effect Factors Analysis 126

  • 13.1 Technology Progress/Risk 126
    • 13.1.1 Technology Progress 126
    • 13.1.2 Peptide Cancer Vaccine by Pipeline 128
  • 13.2 Consumer Needs/Customer Preference Change 140
    • 13.2.1 Key Facts 140
    • 13.2.2 Cancer Incidence and Mortality Analysis 141
  • 13.3 Economic/Political Environmental Change 143

14 Peptide Therapeutics Market Forecast 152

  • 14.1 Global Peptide Therapeutics Sales, Revenue and Price Forecast 152
    • 14.1.1 Global Peptide Therapeutics Sales Growth Forecast (2019-2025) 152
    • 14.1.2 Global Peptide Therapeutics Revenue Growth Forecast (2019-2025) 153
    • 14.1.3 Global Peptide Therapeutics Price Trend Forecast (2019-2025) 154
  • 14.2 Global Peptide Therapeutics Forecast by Region 154
    • 14.2.1 Global Peptide Therapeutics Sales Growth Forecast by Region (2019-2025) 154
    • 14.2.2 Global Peptide Therapeutics Revenue Growth Forecast by Region (2019-2025) 155
    • 14.2.3 North America Peptide Therapeutics Sales, Revenue Growth Forecast (2019-2025) 156
    • 14.2.4 Europe Peptide Therapeutics Sales, Revenue (M USD) Growth Rate Forecast (2019-2025) 157
    • 14.2.5 China Peptide Therapeutics Sales, Revenue Growth Forecast (2019-2025) 158
    • 14.2.6 Japan Peptide Therapeutics Sales, Revenue Growth Forecast (2019-2025) 159
    • 14.2.7 South America Peptide Therapeutics Sales, Revenue Growth Forecast (2019-2025) 160
    • 14.2.8 India Peptide Therapeutics Sales, Revenue Growth Forecast (2019-2025) 161
  • 14.3 Global Peptide Therapeutics Forecast by Type 162
    • 14.3.1 Global Peptide Therapeutics Sales Forecast by Type (2019-2025) 162
    • 14.3.2 Global Peptide Therapeutics Revenue Forecast by Type (2019-2025) 163
    • 14.3.3 Global Peptide Therapeutics Price Forecast by Type (2019-2025) 163
  • 14.4 Global Peptide Therapeutics Forecast by Application 164

15 Research Findings and Conclusion 166

16 Methodology and Data Source 168

  • 16.1 Methodology/Research Approach 168
    • 16.1.1 Research Programs/Design 168
    • 16.1.2 Market Size Estimation 169
    • 16.1.3 Market Breakdown and Data Triangulation 170
  • 16.2 Data Source 172
    • 16.2.1 Secondary Sources 172
    • 16.2.2 Primary Sources 173
  • 16.3 Author List 174
  • 16.4 Disclaimer 175
Back to Top